Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Amortization of Deferred Charges (2019 - 2021)

Biomerica's Amortization of Deferred Charges history spans 3 years, with the latest figure at $62897.0 for Q3 2021.

  • For Q3 2021, Amortization of Deferred Charges rose 9.85% year-over-year to $62897.0; the TTM value through Aug 2021 reached $243228.0, up 8.46%, while the annual FY2021 figure was $237588.0, 11.83% down from the prior year.
  • Amortization of Deferred Charges for Q3 2021 was $62897.0 at Biomerica, down from $63669.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $102456.0 in Q3 2019 and bottomed at $54900.0 in Q4 2019.
  • The 3-year median for Amortization of Deferred Charges is $57768.0 (2020), against an average of $63327.2.
  • The largest annual shift saw Amortization of Deferred Charges plummeted 44.12% in 2020 before it rose 12.83% in 2021.
  • A 3-year view of Amortization of Deferred Charges shows it stood at $54900.0 in 2019, then increased by 5.22% to $57768.0 in 2020, then increased by 8.88% to $62897.0 in 2021.
  • Per Business Quant, the three most recent readings for BMRA's Amortization of Deferred Charges are $62897.0 (Q3 2021), $63669.0 (Q2 2021), and $58894.0 (Q1 2021).